arrow
返回
P

Pingzheng Zhou

Southern Medical University

19H指数
59论文数
1.1K被引数
收录论文 40
发表时间
VRAC coordinates the trade-off between nutrient absorption and antimicrobial defense in enterocytes against inflammationVRAC协调肠上皮细胞在抗炎过程中营养吸收与抗菌防御之间的权衡。
err2026-02-25
err0
errOAAI
errXin Yi; Shiqing Zhang; Xinpei Gu; Xiaoyan Wu; Liang Ma; Yudai Xu; Sha Lv; Jingjing Huang; Yuanxing Zhi; Ying Cao; Xiong Cao; Fengxian Li; Guobing Chen; Shuwen Liu; Ken Kin Lam Yung; Pingzheng Zhou
err分享
err收藏
Discovery of a novel anti-osteoporotic agent from marine fungus-derived structurally diverse sirenins
err2024-02-01
err6
PREAI
errCai, Jian; Gao, Li; Wang, Yue; Zheng, Yuanteng; Lin, Xiuling; Zhou, Pingzheng; Chen, Chunmei; Liu, Kechun; Tang, Lan; Liu, Yonghong; Tan, Yanhui; Jin, Meng; Zhou, Xuefeng
err分享
err收藏
A novel TWIK2 channel inhibitor binds at the bottom of the selectivity filter and protects against LPS-induced experimental endotoxemia in vivo
err2023-12-01
err2
PREAI
errZhi, Yuanxing; Wu, Xiaoyan; Chen, Yanshan; Chen, Xingyuan; Chen, Xiangyu; Luo, Hui; Yi, Xin; Lin, Xiuling; Ma, Liang; Chen, Yao; Cao, Ying; Li, Fengxian; Zhou, Pingzheng
err分享
err收藏
The volume regulated anion channel VRAC regulates NLRP3 inflammasome by modulating itaconate efflux and mitochondria function
err2023-12-01
err7
errOAAI
errWu, Xiaoyan; Yi, Xin; Zhao, Boxin; Zhi, Yuanxing; Xu, Ziwei; Cao, Ying; Cao, Xiong; Pang, Jianxin; Yung, Ken Kin Lam; Zhang, Shiqing; Liu, Shuwen; Zhou, Pingzheng
err分享
err收藏
TRPV4 channel is involved in HSV-2 infection in human vaginal epithelial cells through triggering Ca2+ oscillation
err2022-09-23
err4
errOAAI
errJiang, Ping; Li, Song-shan; Xu, Xin-feng; Yang, Chan; Cheng, Chen; Wang, Jin-shen; Zhou, Ping-zheng; Liu, Shu-wen
err分享
err收藏
Novel DCPIB analogs as dual inhibitors of VRAC/TREK1 channels reduced cGAS-STING mediated interferon responses
err2022-05-01
err4
PREAI
errZhi, Yuanxing; Liu, Jin; Kuang, Peihua; Zhang, Xin; Xu, Ziwei; Chen, Yanshan; Lin, Xiuling; Wu, Xiaoyan; Zhou, Pingzheng; Chen, Jianjun
err分享
err收藏
Pharmacological inhibition of Kv1.3 channel impairs TLR3/4 activation and type I IFN response and confers protection against Listeria monocytogenes infection (vol 177, 106112, 2022)
err2022-04-01
err0
PREAI
errZhang, Xin; Lin, Xiuling; Luo, Hui; Zhi, Yuanxing; Yi, Xin; Wu, Xiaoyan; Duan, Wendi; Cao, Ying; Pang, Jianxin; Liu, Shuwen; Zhou, Pingzheng
err分享
err收藏
Pharmacological inhibition of Kv1.3 channel impairs TLR3/4 activation and type I IFN response and confers protection against Listeria monocytogenes infection
err2022-03-01
err5
PREAI
errZhang, Xin; Lin, Xiulin; Luo, Hui; Zhi, Yuanxing; Yi, Xin; Wu, Xiaoyan; Duan, Wendi; Cao, Ying; Pang, Jianxin; Liu, Shuwen; Zhou, Pingzheng
err分享
err收藏
Discovery of novel verinurad analogs as dual inhibitors of URAT1 and GLUT9 with improved Druggability for the treatment of hyperuricemia
err2022-02-01
err23
PREAI
errZhao, Zean; Liu, Jin; Kuang, Peihua; Luo, Jian; Surineni, Goverdhan; Cen, Xiaolin; Wu, Ting; Cao, Ying; Zhou, Pingzheng; Pang, Jianxin; Zhang, Qun; Chen, Jianjun
err分享
err收藏
CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia (vol 43, pg 121, 2022)
err2022-01-27
err1
errOAAI
errZhao, Ze-an; Jiang, Yu; Chen, Yan-yu; Wu, Ting; Lan, Qun-sheng; Li, Yong-mei; Li, Lu; Yang, Yang; Lin, Cui-ting; Cao, Ying; Zhou, Ping-zheng; Guo, Jia-yin; Tian, Yuan-xin; Pang, Jian-xin
err分享
err收藏
ML365 inhibits TWIK2 channel to block ATP-induced NLRP3 inflammasome
err2021-08-02
err20
errOAAI
errWu, Xiao-yan; Lv, Jin-yan; Zhang, Shi-qing; Yi, Xin; Xu, Zi-wei; Zhi, Yuan-xing; Zhao, Bo-xin; Pang, Jian-xin; Yung, Ken Kin Lam; Liu, Shu-wen; Zhou, Ping-zheng
err分享
err收藏
Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway
err2021-07-01
err60
PREAI
errLi, Yongmei; Zhao, Zean; Luo, Jian; Jiang, Yanqing; Li, Lu; Chen, Yanyu; Zhang, Leqi; Huang, Qinghua; Cao, Ying; Zhou, Pingzheng; Wu, Ting; Pang, Jianxin
err分享
err收藏
CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemiaCDER167是URAT1和GLUT9的双重抑制剂,是治疗高尿酸血症的新型有效的尿酸候选药物。
err2021-03-25
err25
errOAAI
errZhao, Ze An; Jiang, Yu; Chen, Yan-yu; Wu, Ting; Lan, Qun-sheng; Li, Yong-mei; Li, Lu; Yang, Yang; Lin, Cui-ting; Cao, Ying; Zhou, Ping-zheng; Guo, Jia-yin; Tian, Yuan-xin; Pang, Jian-xin
err分享
err收藏
err分享
err收藏